Pneumology - Original Articles

Outcomes of hydropneumothorax among pulmonary tuberculosis patients: a prospective observational study from a tertiary care center in north India

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 13 April 2026
69
Views
51
Downloads

Authors

Hydropneumothorax is an uncommon but serious complication of pulmonary tuberculosis (PTB), often resulting from the rupture of a tuberculous cavity into the pleural space with bronchopleural fistula formation. Early diagnosis and optimal management are crucial to improving outcomes. A descriptive study was conducted over 18 months in 50 microbiologically confirmed PTB patients presenting with pneumothorax or hydropneumothorax at a tertiary care hospital in Punjab, India. Demographic, clinical, radiological, and microbiological data were recorded. Lung expansion was quantified using Light’s Index at serial intervals up to 8 weeks. Statistical analysis was performed using Chi-square/Fisher exact tests; p<0.05 was considered significant. The mean age was 34.48±11.69 years, and 82% were male. All patients presented with breathlessness, 96% with chest pain, 68% with fever, and 62% with cough. New TB cases comprised 82%, recurrent 8%, and loss-to-follow-up 10%. The mean lung expansion time was 2.92±2.16 weeks. Significant associations were found between drainage status and lung expansion (p=0.01) and between type of TB and lung expansion (p=0.04). Complete radiological expansion was achieved in 76% of patients within 8 weeks. Surgical referral to the Cardiothoracic and Vascular Surgery Department was required in 24%. Hydropneumothorax in PTB predominantly affects young adult males and often requires prolonged drainage. Early intercostal tube drainage significantly improves lung expansion outcomes, particularly in new TB cases.

Downloads

Download data is not yet available.

Citations

Gupta D, Mishra S, Faruqi S, et al. Clinical profile, etiology, and management of hydropneumothorax: an Indian experience. Lung India 2016;33:278-82.
Light RW. Pleural Diseases. 7th ed. Philadelphia, PA, USA: Wolters Kluwer; 2023.
Bathobakae T, Malete G, Maganu N, et al. Tuberculous bronchopleural fistula: a rare and life-threatening disease. J Investig Med High Impact Case Rep 2023;11:23247096231220466.
Sharma SK, Mohan A. Tuberculosis. 4th ed. New Delhi, India: Jaypee Brothers Medical Publishers; 2015.
Shen X, Shen C, Zhang Y, Liu J. Surgical management of tuberculous bronchopleural fistula with hydropneumothorax: a case report and literature review. World J Clin Cases 2023;11:2282-9.
Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg2017;153:e129-46.
Dhua A, Chaudhuri AD, Kundu S, et al. Assessment of spontaneous pneumothorax in adults in a tertiary care hospital. Lung India 2015;32:132-6.
Mohan A, Premanand R, Reddy LN, et al. Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit. BMC Pulm Med 2006;6:27.
Sehgal IS, Dhooria S, Aggarwal AN, et al. Diagnostic performance of Xpert MTB/RIF in tuberculous pleural effusion: systematic review and meta-analysis. J Clin Microbiol 2016;54:1133-6.
Gupta D, Hansell A, Nichols Tet al. Epidemiology of pneumothorax in England. Thorax2000;55:666-71.
Kasargod V, Awad NT. Clinical profile, etiology, and management of hydropneumothorax: an Indian experience. Lung India 2016;33:278-80.
Menzies D, Cohen T, Lin HH, et al. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PloS Med 2012;9:e1001347.
Masjedi MR, Tabarsi P, Baghaei P, et al. Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients. Int J Infect Dis 2010;14:e399-402.
Patil SV, Bhagwat RV, Mohite RV, Barphe SS. Clinical profile and treatment outcome of patients with spontaneous pneumothorax. Int J Res Med Sci 2017;5:944-8.
Sousa C, Neves J, Sa N, et al. Spontaneous pneumothorax: a 5-year experience. J Clin Med Res 2011;3:111-7.
Shamaei M, Tabarsi P, Pojhan S, et al. Tuberculosis-associated secondary pneumothorax: a retrospective study of 53 patients. Respir Care 2011;56:298-302.
Sanpurkar MP, Barade SB. Clinical profile, diagnosis and outcome of patients of pneumothorax and hydropneumothorax: observational study. Bharati Vidyapeeth Med J 3:19-23.
Mezghani S, Abdelghani A, Njima H, et al. Tuberculous pneumothorax. Retrospective study of 23 cases in Tunisia. Rev Pneumol Clin 2006;62:13-8.

Ethics Approval

The study was approved by the Institutional Ethics Committee of Guru Gobind Singh Medical College & Hospital, Faridkot (approval No: BFUHS/2K25p-TH/3782).

How to Cite



“Outcomes of Hydropneumothorax Among Pulmonary Tuberculosis Patients: A Prospective Observational Study from a Tertiary Care Center in North India”. 2026. Monaldi Archives for Chest Disease, April. https://doi.org/10.4081/monaldi.2026.3705.